Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients (ISCIW)
Primary Purpose
Affective Disorders, Psychological Stress, Inflammation
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
stress-coping week
additional two days follow-up weekend
Sponsored by
About this trial
This is an interventional prevention trial for Affective Disorders
Eligibility Criteria
Inclusion Criteria:
- Affective or anxiety disorder DSM-IV diagnosis (structured interview, M.I.N.I. International Neuropsychiatric Interview )
- Minimum 3-weeks previous therapeutic treatment as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
- Clinical Global Impression - Severity (CGI-S) score > 2 points
- Minimum improvement of 1 CGI-S points as outpatient
- Written informed consent
Exclusion Criteria:
- More than 60 days away sick per year in the last year before intervention
- Therapy adherence as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
- Work Ability Index (WAI) score < 25 points
- Major neurological or cognitive deficits
- Current psychotic symptoms
- Current or previous DSM-IV diagnosis of substance dependence, except for nicotine or current substance abuse
- Failures to comply with the study protocol or to follow the instructions of the study team
- Currently requested application for retirement
- Middle to high suicidal tendency in the M.I.N.I.-examination
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Active Comparator
Active Comparator
Arm Label
Waiting list, intervention after EOS
Stress-coping week without follow-up
Stress-coping week with follow-up
Arm Description
control group / waiting list one week stress-coping intervention planned after end of study (EOS) without one week stress-coping intervention AND without an additional two days follow-up care
active comparator with one week stress-coping intervention BUT without an additional two days follow-up weekend
active comparator with one week stress-coping intervention AND with an additional two days follow-up weekend
Outcomes
Primary Outcome Measures
Change of saliva cortisol
Secondary Outcome Measures
Change of myeloperoxidase
Change of interleukin-6
Change of homocystein
Change of psychometric stress-index (Questionnaire)
Full Information
NCT ID
NCT02752295
First Posted
April 7, 2016
Last Updated
September 15, 2016
Sponsor
Medical University of Vienna
Collaborators
Sanatorium Hera Vienna
1. Study Identification
Unique Protocol Identification Number
NCT02752295
Brief Title
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
Acronym
ISCIW
Official Title
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
May 2015 (undefined)
Primary Completion Date
July 2016 (Actual)
Study Completion Date
July 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Vienna
Collaborators
Sanatorium Hera Vienna
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.
Detailed Description
Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Affective Disorders, Psychological Stress, Inflammation, Oxidative Stress, Anxiety Disorders, Mood Disorders, Emotions
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Waiting list, intervention after EOS
Arm Type
No Intervention
Arm Description
control group / waiting list one week stress-coping intervention planned after end of study (EOS) without one week stress-coping intervention AND without an additional two days follow-up care
Arm Title
Stress-coping week without follow-up
Arm Type
Active Comparator
Arm Description
active comparator with one week stress-coping intervention BUT without an additional two days follow-up weekend
Arm Title
Stress-coping week with follow-up
Arm Type
Active Comparator
Arm Description
active comparator with one week stress-coping intervention AND with an additional two days follow-up weekend
Intervention Type
Behavioral
Intervention Name(s)
stress-coping week
Intervention Description
The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.
Intervention Type
Behavioral
Intervention Name(s)
additional two days follow-up weekend
Intervention Description
A two-days follow-up which recapitulates previous treatment elements.
Primary Outcome Measure Information:
Title
Change of saliva cortisol
Time Frame
Change from baseline saliva sample at week 1 to end of study visit at week 38
Secondary Outcome Measure Information:
Title
Change of myeloperoxidase
Time Frame
Change from baseline at week 1 to end of study visit at week 38
Title
Change of interleukin-6
Time Frame
Change from baseline at week 1 to end of study visit at week 38
Title
Change of homocystein
Time Frame
Change from baseline at week 1 to end of study visit at week 38
Title
Change of psychometric stress-index (Questionnaire)
Time Frame
Change from baseline at week 1 to end of study visit at week 38
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Affective or anxiety disorder DSM-IV diagnosis (structured interview, M.I.N.I. International Neuropsychiatric Interview )
Minimum 3-weeks previous therapeutic treatment as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
Clinical Global Impression - Severity (CGI-S) score > 2 points
Minimum improvement of 1 CGI-S points as outpatient
Written informed consent
Exclusion Criteria:
More than 60 days away sick per year in the last year before intervention
Therapy adherence as outpatient at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria
Work Ability Index (WAI) score < 25 points
Major neurological or cognitive deficits
Current psychotic symptoms
Current or previous DSM-IV diagnosis of substance dependence, except for nicotine or current substance abuse
Failures to comply with the study protocol or to follow the instructions of the study team
Currently requested application for retirement
Middle to high suicidal tendency in the M.I.N.I.-examination
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
24513877
Citation
Pilger A, Haslacher H, Ponocny-Seliger E, Perkmann T, Bohm K, Budinsky A, Girard A, Klien K, Jordakieva G, Pezawas L, Wagner O, Godnic-Cvar J, Winker R. Affective and inflammatory responses among orchestra musicians in performance situation. Brain Behav Immun. 2014 Mar;37:23-9. doi: 10.1016/j.bbi.2013.10.018. Epub 2013 Oct 26.
Results Reference
background
Learn more about this trial
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
We'll reach out to this number within 24 hrs